Vein Immunoglobulin Therapy may Induce Pancreatic Damage in Myasthenic Patients: A Case Report

Journal Title: Journal of Neurology and Experimental Neuroscience - Year 2017, Vol 3, Issue 1

Abstract

Background: Myasthenia gravis (MG) is an autoimmune neurological disease characterized by fluctuating fatigable skeletal muscle weakness that represents a challenge for physicians due to the diversity of the disease manifestations and the possibility of fatal complications. Case report: We report the case of a 45-year-old female patient with myasthenia gravis, who developed reversible signs of pancreatic damage, probably related to immunoglobulin vein infusion therapy (IGiv). During this treatment, the patients had an increase of the serum pancreatic enzymes, greater than five times the upper limit of normal values, resolved, without treatment, after the suspension of IGiv. Moreover, a magnetic resonance with cholangiography, showed a slight hyperintensity of the head of the pancreas. Conclusions: The close temporal relationship between the vein infusion of immunoglobulin and the increase of serum pancreatic enzymes in our patient suggests that IGiv may have a toxic effect on the pancreatic cells that disappears with the suspension of IGiv.

Authors and Affiliations

Gaetano Gorgone, Carmen Colica, Massimiliano Plastino, Antonietta Fava, Dario Cristiano, Demetrio Messina, Alessandra Fratto, Domenico Bosco

Keywords

Related Articles

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain

Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to its receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface. Recent studies indicate that neurons bu...

Morphological Studies of Wobbler Mouse Dorsal Root Ganglia Show Neurofilamental Disorders

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with three described forms: The abundant, sporadic ALS (sALS) with approximately 90% of cases, the familial ALS (fALS) with 5-10%, and the very rar...

Frequency and Outcomes of Early Onset Seizures after Ischemic Stroke

Introduction: Stroke is most common cause of new onset seizures in elderly. In this study, we assessed frequency and outcome by National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) in early o...

Cellular and Molecular Mechanisms of Retinal Ganglion Cell Death in Hypoxic-Ischemic Injuries

Loss of retinal ganglion cells (RGCs) occurs in retinal degenerative diseases, such as glaucoma, age-related macular degeneration, diabetic retinopathy, central retinal artery occlusion and ischemic central retinal vein...

Multidisciplinary Approach to Chronic Pelvic Pain

Chronic pelvic pain is a common medical condition affecting up to 16 percent of reproductive-aged women. There are many possible etiologies of chronic pelvic pain ranging from gynecologic to non-gynecologic. Treatment is...

Download PDF file
  • EP ID EP223863
  • DOI 10.17756/jnen.2017-019
  • Views 105
  • Downloads 0

How To Cite

Gaetano Gorgone, Carmen Colica, Massimiliano Plastino, Antonietta Fava, Dario Cristiano, Demetrio Messina, Alessandra Fratto, Domenico Bosco (2017). Vein Immunoglobulin Therapy may Induce Pancreatic Damage in Myasthenic Patients: A Case Report. Journal of Neurology and Experimental Neuroscience, 3(1), 8-10. https://europub.co.uk/articles/-A-223863